In contrast, we observed the opposite phenotypic and molecular changes in VCaP human prostate cancer cells harboring the recurrent TMPRSS2-ERG fusion (Fig. 1c, d & Supplementary Fig. 2c, d). Here, ERG is linked to prostate carcinoma.